Gilead Sciences, Inc.

weak sauce

99
The Dec/Mar highs have capped price post earnings. This thing was halted...everybody was looking for a monster move...the analysts were way off, but the quarter's news appears mostly baked in. This sets up an interesting fade opportunity. (Personally am looking at the May 70-65 Put spread as it really limits risk if wrong and all the extra IV is getting sucked out)

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。